The Veteran was granted a 60 percent disability rating for his skin disability and a separate 10 percent rating for scarring of bilateral facial cheeks due to chloracne, effective July 14, 2022.
The deciding factor: The Veteran's treatment required constant or near-constant systemic therapy, which meets the criteria for a 60 percent rating under the General Rating Formula for the Skin. The presence of one characteristic of disfigurement also supports a separate 10 percent rating for scarring of bilateral facial cheeks.
- Claimed conditions
- chloracne, scarring of bilateral facial cheeks due to chloracne
- How they argued it
- Reopened with new and material evidence
- Exposure basis
- None
- Rating assigned
- 60%
- Decision date
- March 26, 2025
- Citation
- A25028361
Veterans Law Judge
Decisions by this judge: 2,170 · Granted: 38% (granted or partly granted, in the vetted decisions on this site)
Judge attribution: 2025 complete; earlier years partial.
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation A25028361.
What this means for you
A grant means the Board agreed the veteran was entitled to the benefit. Decisions like this show the kind of evidence and arguments that tend to succeed for claims like it.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Remanded (sent back)
The Veteran's spouse is seeking to be substituted as the appellant for claims of service connection filed by the Veteran in August 2017. The AOJ has not yet determined whether she meets the requirements to substitute, and this issue must be remanded.
- Granted
The Veteran's chloracne is presumed to be caused by his exposure to herbicide agents during service, and the Board has granted service connection for this condition.
- Denied
The Veteran's claim for an initial disability rating in excess of 10 percent for chloracne with pilonidal cyst associated with TERA participation was denied, and the claim for an effective date prior to July 29, 2024, for service connection was also denied.
- Remanded (sent back)
The Board remands the claims for further development, including obtaining additional medical opinions and private treatment records.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.